Cargando…
Identifying predictive signalling networks for Vedolizumab response in ulcerative colitis
BACKGROUND: In ulcerative colitis (UC), the molecular mechanisms that drive disease development and patient response to therapy are not well understood. A significant proportion of patients with UC fail to respond adequately to biologic therapy. Therefore, there is an unmet need for biomarkers that...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167201/ https://www.ncbi.nlm.nih.gov/pubmed/35543875 http://dx.doi.org/10.1007/s00384-022-04176-w |